Texas Instruments Insider Sold Shares Worth $892,427, According to a Recent SEC Filing-February 2024-www.financetom.com

Texas Instruments Insider Sold Shares Worth $892,427, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Texas Instruments Insider Sold Shares Worth $892,427, According to a Recent SEC Filing

Aug 31, 2024 9:02 AM

05:46 PM EDT, 08/29/2024 (MT Newswires) -- Ahmad Bahai, Senior Vice President, on August 27, 2024, sold 4,250 shares in Texas Instruments ( TXN ) for $892,427. Following the Form 4 filing with the SEC, Bahai has control over a total of 35,020 shares of the company, with 35,020 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/97476/000112760224023181/xslF345X05/form4.xml

Previous page： Why Is Accolade Stock Trading Over 100% On Tuesday? Next page： Nordson Insider Sold Shares Worth $268,620, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Why Is Accolade Stock Trading Over 100% On Tuesday?

Jan 8, 2025

Transcarent agreed to buy Accolade Inc Wednesday for $621 million. The purchase price works out to $7.03 per share in cash. Accolade is a Personalized Healthcare company that offers employer, health plan, and consumer solutions combined with virtual primary care and mental health, medical opinion, and care navigation. The transaction is expected to bring Transcarent’s generative AI-powered WayFinding and comprehensive care experiences —...

Nordson Insider Sold Shares Worth $268,620, According to a Recent SEC Filing

Jan 8, 2025

01:37 PM EST, 01/08/2025 (MT Newswires) -- Stephen Lovass, Executive Vice President, on January 06, 2025, sold 1,299 shares in Nordson ( NDSN ) for $268,620. Following the Form 4 filing with the SEC, Lovass has control over a total of 7,546 shares of the company, with 7,347 shares held directly and 199 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/72331/000007233125000012/xslF345X05/wk-form4_1736361253.xml Price: 203.84,...

Why CureVac (CVAC) Stock Is Moving

Jan 8, 2025

Shares of CureVac BV fell by 12.3% to $4.10 Wednesday afternoon. The pullback could be due to profit-taking after Tuesday's strong gains, which were fueled by heightened concerns over respiratory illnesses across the U.S. The surge in healthcare visits, driven by higher cases of seasonal influenza, COVID-19 and RSV, has renewed interest in vaccine and therapeutic manufacturers this week. Read...

Jan 8, 2025

...